UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 56

Sortiert nach

Quantitative proteomic analysis of HER2 expression in the selection of gastric cancer patients for trastuzumab treatment

Annals of oncology, 2017-01, Vol.28 (1), p.110-115

2017

Volltextzugriff (PDF)

Phase II study of a trastuzumab biosimilar in combination with paclitaxel for HER2-positive recurrent or metastatic urothelial carcinoma: KCSG GU18-18

ESMO open, 2023-08, Vol.8 (4), p.101588, Article 101588

2023

Volltextzugriff (PDF)

1704P Multimodal approach to discover novel targets for antibody-drug conjugates by analyzing distinct expression patterns of frequent copy number aberration

Annals of oncology, 2022-09, Vol.33, p.S1319

2022

Volltextzugriff (PDF)

1706P Artificial intelligence-powered tumor purity assessment from H&E whole slide images associates with variant allele frequency of somatic mutations across 23 cancer types in TCGA cohorts

Annals of oncology, 2022-09, Vol.33, p.S1320

2022

Volltextzugriff (PDF)

569P Artificial intelligence for detection of mismatch repair deficiency in colon carcinomas (alliance)

Annals of oncology, 2023-10, Vol.34, p.S420-S420

2023

Volltextzugriff (PDF)

94P Performance validation of an artificial intelligence-powered programmed death-ligand 1 (PD-L1) combined positive score analyzer in urothelial cancer

Annals of oncology, 2022-09, Vol.33, p.S581-S582

2022

Volltextzugriff (PDF)

900P AI-powered analyzer reveals enrichment of intra-tumoral tumor-infiltrating lymphocytes in high-grade neuroendocrine neoplasms

Annals of oncology, 2022-09, Vol.33, p.S959

2022

Volltextzugriff (PDF)

355O Artificial intelligence-powered spatial analysis of tumor microenvironment (TME) in nasopharyngeal carcinoma (NPC) patients treated with immune checkpoint inhibitors (ICI)

Annals of oncology, 2023-11, Vol.34, p.S1608

2023

Volltextzugriff (PDF)

118P Artificial intelligence (AI)-powered spatial analysis of tumor-infiltrating lymphocytes (TILs) as a predictive biomarker for anti-PD-1 in advanced biliary tract cancer (BTC)

Annals of oncology, 2023-10, Vol.34, p.S226-S226

2023

Volltextzugriff (PDF)

2330P Pre-test prediction of multiple druggable mutations based on H&E image artificial intelligence (AI) analysis may enable more efficient clinical workflow for treatment decisions in non-small cell lung cancer (NSCLC)

Annals of oncology, 2023-10, Vol.34, p.S1189-S1190

2023

Volltextzugriff (PDF)

571P Artificial intelligence-powered analysis of tumor lymphocytes infiltration: A translational analysis of AtezoTRIBE trial

Annals of oncology, 2023-10, Vol.34, p.S421-S421

2023

Volltextzugriff (PDF)

874P Artificial intelligence (AI)-powered spatial tumor-infiltrating lymphocyte (TIL) analysis in recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC) patients treated with immune checkpoint inhibitor (ICI) treatment

Annals of oncology, 2023-10, Vol.34, p.S564-S564

2023

Volltextzugriff (PDF)

977P Interim results of phase I dose escalation study of YBL-006: A novel anti-PD-1 monoclonal antibody in advanced solid tumors

Annals of oncology, 2021-09, Vol.32, p.S838-S838

2021

Volltextzugriff (PDF)

270P Phase Ib study of venadaparib, a potent and selective PARP inhibitor, in homologous recombination repair (HRR) mutated breast cancer

Annals of oncology, 2021-09, Vol.32, p.S480-S480

2021

Volltextzugriff (PDF)

P1.21-20 Tertiary Lymphoid Structures Assessed by an AI-powered Analysis of H&E Images is Correlated with Favorable Outcomes of Immunotherapy in NSCLC

Journal of thoracic oncology, 2023-11, Vol.18 (11), p.S243

2023

Volltextzugriff (PDF)

155P Artificial Intelligence (AI) - powered human epidermal growth factor receptor-2 (HER2) and tumor-infiltrating lymphocytes (TIL) analysis for HER2-positive early breast cancer patients treated with HER2-targeted neoadjuvant chemotherapy (NAC)

Annals of oncology, 2022-09, Vol.33, p.S610

2022

Volltextzugriff (PDF)

1453P Safety and efficacy of vactosertib, a TGF-βR1 kinase inhibitor, in combination with paclitaxel in patients with metastatic gastric adenocarcinoma

Annals of oncology, 2020-09, Vol.31, p.S912-S912

2020

Volltextzugriff (PDF)

398P AI-powered whole-slide image analysis of tumor-infiltrating lymphocytes for prediction of prognosis in colorectal cancer

Annals of oncology, 2021-09, Vol.32, p.S537-S537

2021

Volltextzugriff (PDF)

1805P Assistance with an artificial intelligence-powered PD-L1 analyzer reduces interobserver variation in pathologic reading of tumor proportion score in non-small cell lung cancer

Annals of oncology, 2021-09, Vol.32, p.S1228-S1228

2021

Volltextzugriff (PDF)

Phase II study of osimertinib in NSCLC patients with EGFR exon 20 insertion mutation: A multicenter trial of the Korean Cancer Study Group (LU17-19)

Annals of oncology, 2019-10, Vol.30, p.v628

2019

Volltextzugriff (PDF)

1529P - Phase II study of osimertinib in NSCLC patients with EGFR exon 20 insertion mutation: A multicenter trial of the Korean Cancer Study Group (LU17-19)

Annals of oncology, 2019-10, Vol.30, p.v628-v628

2019

Volltextzugriff (PDF)

1529PPhase II study of osimertinib in NSCLC patients with EGFR exon 20 insertion mutation: A multicenter trial of the Korean Cancer Study Group (LU17-19)

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

Quantitative Structure−Activity Relationship Study of Bitter Peptides

Journal of agricultural and food chemistry, 2006-12, Vol.54 (26), p.10102-10111

2006

Volltextzugriff (PDF)

Quantification of Polyphenolics and Their Antioxidant Capacity in Fresh Plums

Journal of agricultural and food chemistry, 2003-10, Vol.51 (22), p.6509-6515

2003

Volltextzugriff (PDF)

Superoxide Radical Scavenging Activity of the Major Polyphenols in Fresh Plums

Journal of agricultural and food chemistry, 2003-12, Vol.51 (27), p.8067-8072

2003

Volltextzugriff (PDF)

1 – 25 von 56

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(51)
Mit Volltextzugriff
(55)

Publikationsform

Artikel
(55)
Buchkapitel
(1)

Sprache

Englisch
(56)
Japanisch
(11)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(35)
Life Sciences & Biomedicine
(33)
Biological And Medical Sciences
(19)
Humans
(12)
Pharmacology & Pharmacy
(12)
Animals
(11)
Fundamental And Applied Biological Sciences. Psychology
(10)
Medical Sciences
(10)
Pharmacology. Drug Treatments
(10)
Chemistry
(9)
Food Science & Technology
(9)
General Pharmacology
(9)
Pharmacognosy. Homeopathy. Health Food
(9)
Physical Sciences
(9)
Chemistry, Applied
(7)
Agriculture
(6)
Agriculture, Multidisciplinary
(6)
Mice
(6)
Chemistry, Medicinal
(5)
Food Industries
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Quantitative proteomic analysis of HER2 expression in the selection of gastric cancer patients for trastuzumab treatment

Phase II study of a trastuzumab biosimilar in combination with paclitaxel for HER2-positive recurrent or metastatic urothelial carcinoma: KCSG GU18-18

1704P Multimodal approach to discover novel targets for antibody-drug conjugates by analyzing distinct expression patterns of frequent copy number aberration

1706P Artificial intelligence-powered tumor purity assessment from H&E whole slide images associates with variant allele frequency of somatic mutations across 23 cancer types in TCGA cohorts

569P Artificial intelligence for detection of mismatch repair deficiency in colon carcinomas (alliance)

94P Performance validation of an artificial intelligence-powered programmed death-ligand 1 (PD-L1) combined positive score analyzer in urothelial cancer

900P AI-powered analyzer reveals enrichment of intra-tumoral tumor-infiltrating lymphocytes in high-grade neuroendocrine neoplasms

355O Artificial intelligence-powered spatial analysis of tumor microenvironment (TME) in nasopharyngeal carcinoma (NPC) patients treated with immune checkpoint inhibitors (ICI)

118P Artificial intelligence (AI)-powered spatial analysis of tumor-infiltrating lymphocytes (TILs) as a predictive biomarker for anti-PD-1 in advanced biliary tract cancer (BTC)

2330P Pre-test prediction of multiple druggable mutations based on H&E image artificial intelligence (AI) analysis may enable more efficient clinical workflow for treatment decisions in non-small cell lung cancer (NSCLC)

571P Artificial intelligence-powered analysis of tumor lymphocytes infiltration: A translational analysis of AtezoTRIBE trial

874P Artificial intelligence (AI)-powered spatial tumor-infiltrating lymphocyte (TIL) analysis in recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC) patients treated with immune checkpoint inhibitor (ICI) treatment

977P Interim results of phase I dose escalation study of YBL-006: A novel anti-PD-1 monoclonal antibody in advanced solid tumors

270P Phase Ib study of venadaparib, a potent and selective PARP inhibitor, in homologous recombination repair (HRR) mutated breast cancer

P1.21-20 Tertiary Lymphoid Structures Assessed by an AI-powered Analysis of H&E Images is Correlated with Favorable Outcomes of Immunotherapy in NSCLC

155P Artificial Intelligence (AI) - powered human epidermal growth factor receptor-2 (HER2) and tumor-infiltrating lymphocytes (TIL) analysis for HER2-positive early breast cancer patients treated with HER2-targeted neoadjuvant chemotherapy (NAC)

1453P Safety and efficacy of vactosertib, a TGF-βR1 kinase inhibitor, in combination with paclitaxel in patients with metastatic gastric adenocarcinoma

398P AI-powered whole-slide image analysis of tumor-infiltrating lymphocytes for prediction of prognosis in colorectal cancer

1805P Assistance with an artificial intelligence-powered PD-L1 analyzer reduces interobserver variation in pathologic reading of tumor proportion score in non-small cell lung cancer

Phase II study of osimertinib in NSCLC patients with EGFR exon 20 insertion mutation: A multicenter trial of the Korean Cancer Study Group (LU17-19)

1529P - Phase II study of osimertinib in NSCLC patients with EGFR exon 20 insertion mutation: A multicenter trial of the Korean Cancer Study Group (LU17-19)

1529PPhase II study of osimertinib in NSCLC patients with EGFR exon 20 insertion mutation: A multicenter trial of the Korean Cancer Study Group (LU17-19)

Quantitative Structure−Activity Relationship Study of Bitter Peptides

Quantification of Polyphenolics and Their Antioxidant Capacity in Fresh Plums

Superoxide Radical Scavenging Activity of the Major Polyphenols in Fresh Plums

Suchergebnisse filtern